EXACT BIOCHIP CORP.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
The "Disposable-Gate Nanoelectronic Biomedical Detection Platform" technology is a world-leading, innovative detection method. Its sensitivity has reached the sub-fM (< 10^-15 M) level, which is over a thousand times higher than currently used detection methods, while reducing the detection time from several hours to just 20 minutes. The technical team has successfully completed validation for various target analytes, including Botulinum toxin, Hepatitis B antigen proteins, and Streptococcus pneumoniae. Featuring 8 channels with continuous scalability, this detection platform can simultaneously detect different biomarkers, providing an outstanding diagnostic tool for early-stage cancer and other diseases.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2010
Unified Business No.
53273394
Status
Active
Number of Employees
0
Total Paid-in
Capital
16,400,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Shen Zheng Biotech was established through investments from multiple National Chiao Tung University alumni and owners of listed and OTC semiconductor companies in the Hsinchu Science Park. The Chairman is Mr. Kuei-Jui Li, President of Cheng-Hsien Technology Group, a world-renowned ophthalmic laser medical equipment manufacturer. Currently stationed in the National Chiao Tung University Incubation Center, the company is actively executing its global patent layout. Having acquired the technology transfer of the "Disposable-Gate Nanoelectronic Biomedical Detection Platform" from National Chiao Tung University, Shen Zheng Biotech can target early-stage cancer and disease etiology detection, becoming a powerful weapon in the fight against cancer and various viruses.
(The content above was translated by AI.)
(The content above was translated by AI.)
